Results 151 to 160 of about 59,431 (239)

Survivin recombinant overlapping peptide (ROP) vaccine in advanced solid tumours: a first-in-human, multicentre, open-label, phase 1a dose-escalation study. [PDF]

open access: yesEClinicalMedicine
Wijaya W   +9 more
europepmc   +1 more source

Pleiotropic Effects of 3-<i>O</i>-Decanoylquercetin on U373-MG Human Glioma Cell Line. [PDF]

open access: yesInt J Mol Sci
Dell'Albani P   +4 more
europepmc   +1 more source

Targeting Survivin: Now I Become Death, the Destroyer of Cells. [PDF]

open access: yesInt J Mol Sci
Fanuzzi M   +12 more
europepmc   +1 more source

Restoring apoptosis in breast cancer via peptide mediated disruption of survivin IAP interaction. [PDF]

open access: yesSci Rep
Taghavifar SM   +4 more
europepmc   +1 more source

Switching off CK2-mediated activation of survivin offers new therapeutic opportunities in neuroblastoma. [PDF]

open access: yesExp Mol Med
Cazzanelli G   +13 more
europepmc   +1 more source

YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer. [PDF]

open access: yesPharmaceuticals (Basel)
Ruiz de Porras V   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy